EISAI INC. for EISAI INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
S. 2260 -- EXPIRE Act of 2014 -- Issues Related to Tax Reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Defense DEF
DoD/TRICARE coverage of FDA-approved obesity medications H.R. 4435/S. 2410 -- National Defense Authorization bill for 2015 H.R. 4870 -- Department of Defense Appropriations Bill for 2015 (including H.R. 83 - Consolidated and Further Continuing Appropriations Act of FY15)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
| STEPHEN D MCMILLAN | — |
Medicare/Medicaid MMM
H.R. 2415/S. 1184 -- Treat and Reduce Obesity Act of 2013 -- Medicare Part D H.R. 2810 -- Medicare Patient Access and Quality Improvement Act of 2013 -- Medicare Part B and D patient access and choice H.R. 4302 Protecting Access to Medicare Act of 2014 (SGR Patch) - P.L. 113-93 -- Medicare Part B Patient Access
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
| STEPHEN D MCMILLAN | — |
Health Issues HCR
H.R. 3890/S. 1932 -- Better Care, Lower Cost Act Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Budget/Appropriations BUD
H.R. 4870 -- Department of Defense Appropriations Act of 2015 -- DoD/TRICARE Issues HJ Res 124 -- Continuing Appropriations Resolution 2015 - DoD/TRICARE Issues, Medicare Issues (pharmaceutical reimbursement offsets, coverage of obesity Rx products) H.R. 83 -- Consolidated and Further Continuing Appropriations Act of 2015 (P.L. 113-235) -- Included FY 15 DoD Appropriations (DoD/TRICARE coverage of obesity drugs)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
| STEPHEN D MCMILLAN | — |
Pharmacy PHA
DEA Scheduling of Controlled Substances H.R. 4299 -- Improving Regulatory Transparency for New Medical Therapies Act S. 2862 -- Transparency, Patient Access and Effective Drug Enforcement Act of 2014
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.